University Hospital
Ghent, Oost-Vlaanderen, 9000, Belgium
NCT Number: NCT03182361
Patients with craniofacial defects caused by oncologic resection, traumatic events or congenital etiologies suffer from esthetic, functional and psychological problems. Auricular, nasal and orbital defects can be reconstructed with implant retained extra-oral prosthesis. The goal of this study is to evaluate implant survival in temporal, maxillary and orbital bone, and peri-implant tissue reactions using a new implant system developed by BioComp Industries.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ghent, Oost-Vlaanderen, 9000, Belgium
Protocol:
In normal circumstances, without bone limitations, the number and location of the implants will be planned as mentioned below:
If for some reason there is insufficient bone in the above mentioned areas, the position of the implants will be minimally adjusted in order to secure good osseointegration. Neuronavigation will be used for cases with limited bone volume.
For auricular, orbital and nasal defects with sufficient bone volume (>=3mm) and good bone quality, a percutaneous healing abutment with torque 20-25 ncm will be placed immediately after insertion of the implant (=one-stage protocol). Soft tissues in an area of 15-20mm surrounding the implant will be reduced to 1mm thickness.
In all other circumstances, the implant will be protected by means of a cover screw and reburied under the skin for a 3 month osseointegration period (=two-stage protocol). After 3 months the implants are exposed, percutaneous healing abutments placed and the surrounding soft tissues reduced to 1mm thickness.
In the case of large resections where no viable skin is left, a split thickness skin graft from the upper thigh will be used.
Finally, a healing cap surrounding the healing abutments is placed to ensure strong bone-skin contact around the implant. This healing cap will be fixated by a fixation screw, torqued at 15 Ncm.
The stability of the implants will be measured at the time of abutment placement, 1 or 2 weeks, 1 month, 3 months, 6 months and yearly until the end of the study by resonance frequency analysis (RFA), using the Osstell idx system.
At the same time periods the peri-abutment tissue will be evaluated according to the Holgers criteria.
Once all implants have reached a stability measurement of 50 ISQ, the patient will be sent to the anaplastologist for prosthesis treatment.
In case one or more of the implants fail during the study period, the implant will be removed and replaced by a new implant. The protocol will restart for the newly placed implant.
The bone level around the implants will be measured at 1 or 2 weeks after implant placement and 1 year after implant placement. Radiological imaging will be performed using a cone beam computed tomography device (planmeca promax 3d max) or CT scan, dependent on primary imaging in order to allow comparison between both images.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placement of BioComp Industries extraoral screw implants with diameters 3.4mm or 4mm and lengths 3.4mm or 4mm in temporal, nasal or orbital bone
Other names: EO-1110-34VD04, EO-1110-40VD03, EO-1110-40VD04
Time frame: 1 year
Implant stability measurement with Osstell IDX system
Time frame: 1 year
Measurement of peri-implant pockets and soft tissue according to Holgers criteria
Time frame: 1-2 weeks post-operative, 1 year
Bone level measurement using CBCT or CT scan
University Hospital, Ghent
Other
Implant Survival and Peri-abutment Tissue Reactions of Extra-oral Implants: An Interventional Study of 10 Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02793726
Prostheses and Implants
Bologna, Italy
View Trial DetailsNCT04197011
Prostheses and Implants
Nottingham, Notts, United Kingdom
View Trial DetailsNCT06275282
Amputation, Prostheses and Implants
Ann Arbor, Michigan, United States
View Trial Details